drugset / Trial / NCT02521857

A Water Consumption Study of ALKS 5461 in Healthy Volunteers

NCT02521857

Phase 1 Completed 30 enrolled Alkermes, Inc.
NaSingle-groupOpen-labelTreatment

Summary

This study will evaluate the impact of water consumption on the pharmacokinetics of ALKS 5461.

Timeline

Start
2015-07
Primary completion
2015-09
Completion
2015-09

Drugs

EvaluationDrugModalityDoseRoute
Subject ALKS 5461 Unknown Other

Indications

No indication recorded.